David L. Sigalet
Dept. of Surgery
Alberta Children's Hospital
2888 Shaganappi Trail NW
Calgary
Name/email consistency: high
- Glucagon-like peptide 2 induces vasoactive intestinal polypeptide expression in enteric neurons via phophatidylinositol 3-kinase-γ signaling. de Heuvel, E., Wallace, L., Sharkey, K.A., Sigalet, D.L. Am. J. Physiol. Endocrinol. Metab. (2012)
- The effects of glucagon-like peptide 2 on enteric neurons in intestinal inflammation. Sigalet, D.L., Wallace, L., De Heuval, E., Sharkey, K.A. Neurogastroenterol. Motil. (2010)
- The assessment, and glucagon-like peptide-2 modulation, of intestinal absorption and function. Sigalet, D.L., Lam, V., Boctor, D. Semin. Pediatr. Surg. (2010)
- Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Sigalet, D., Boctor, D., Robertson, M., Lam, V., Brindle, M., Sarkhosh, K., Driedger, L., Sajedi, M. Eur. J. Pediatr. Surg (2009)
- Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Sigalet, D.L., Wallace, L.E., Holst, J.J., Martin, G.R., Kaji, T., Tanaka, H., Sharkey, K.A. Am. J. Physiol. Gastrointest. Liver Physiol. (2007)
- Long term cardiopulmonary effects of closed repair of pectus excavatum. Sigalet, D.L., Montgomery, M., Harder, J., Wong, V., Kravarusic, D., Alassiri, A. Pediatr. Surg. Int. (2007)
- Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum. Sigalet, D.L., Bawazir, O., Martin, G.R., Wallace, L.E., Zaharko, G., Miller, A., Zubaidi, A. Dig. Dis. Sci. (2006)
- A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. Sigalet, D.L., Martin, G.R., Butzner, J.D., Buret, A., Meddings, J.B. J. Pediatr. Surg. (2005)
- 3-0 methylglucose uptake as a marker of nutrient absorption and bowel length in pediatric patients. Sigalet, D.L., Martin, G.R., Meddings, J.B. JPEN. J. Parenter. Enteral. Nutr (2004)
- GLP-2 levels in infants with intestinal dysfunction. Sigalet, D.L., Martin, G., Meddings, J., Hartman, B., Holst, J.J. Pediatr. Res. (2004)
- Combined immunosuppression with cyclosporine, rapamycin, and mycophenolate mofetil controls rejection with minimal nutritional impact in experimental small intestinal transplantation. Sigalet, D.L., Thorne, P.C., Martin, G.R., Garola, R.E., Yatscoff, R.W. Transplant. Proc. (2002)
- ALX-0600 (NPS Allelix Corp). Sigalet, D.L. Curr. Opin. Investig. Drugs (2001)
- Nutritional effects of surgical and medical treatment for short bowel syndrome. Sigalet, D.L., Lees, G.M., Aherne, F.X., Fedorak, R., Keelan, M., Thomson, A.B., van Aerde, J. JPEN. J. Parenter. Enteral. Nutr (2001)









